Natural compounds from herbs and nutraceuticals as glycogen synthase kinase‐3β inhibitors in Alzheimer's disease treatment DOI Creative Commons
Zheng Zhao, Ye Yuan, Shuang Li

и другие.

CNS Neuroscience & Therapeutics, Год журнала: 2024, Номер 30(8)

Опубликована: Авг. 1, 2024

Abstract Background Alzheimer's disease (AD) pathogenesis is complex. The pathophysiology not fully understood, and safe effective treatments are needed. Glycogen synthase kinase 3β (GSK‐3β) mediates AD progression through several signaling pathways. Recently, studies have found that various natural compounds from herbs nutraceuticals can significantly improve symptoms. Aims This review aims to provide a comprehensive summary of the potential neuroprotective impacts as inhibitors GSK‐3β in treatment AD. Materials Methods We conducted systematic literature search on PubMed, ScienceDirect, Web Science, Google Scholar, focusing vitro vivo investigated Results mechanism may be related activation inhibition regulate amyloid beta production, tau protein hyperphosphorylation, cell apoptosis, cellular inflammation. By reviewing recent phytochemicals intervention, flavonoids including oxyphylla A, quercetin, morin, icariin, linarin, genipin, isoorientin were reported potent for treatment. Polyphenols such schisandrin B, magnolol, dieckol inhibitory effects models, models. Sulforaphene, ginsenoside Rd, gypenoside XVII, falcarindiol, epibrassinolides, 1,8‐Cineole, andrographolide promising inhibitors. Conclusions Natural candidates They qualify derivatives development enhanced pharmacological characteristics.

Язык: Английский

Therapeutic application of natural products: NAD+ metabolism as potential target DOI
Guo Chen, Qingxia Huang,

Yisa Wang

и другие.

Phytomedicine, Год журнала: 2023, Номер 114, С. 154768 - 154768

Опубликована: Март 13, 2023

Язык: Английский

Процитировано

48

The neuroprotective mechanisms of naringenin: Inhibition of apoptosis through the PI3K/AKT pathway after hypoxic-ischemic brain damage DOI
Luyao Li, Zhen Lin, Junhui Yuan

и другие.

Journal of Ethnopharmacology, Год журнала: 2023, Номер 318, С. 116941 - 116941

Опубликована: Июль 20, 2023

Язык: Английский

Процитировано

37

Methods on improvements of the poor oral bioavailability of ginsenosides: Pre-processing, structural modification, drug combination, and micro- or nano- delivery system DOI Creative Commons

Qi‐rui Hu,

Huan Hong, Zhihong Zhang

и другие.

Journal of Ginseng Research, Год журнала: 2023, Номер unknown

Опубликована: Июль 1, 2023

Panax ginseng Meyer is a traditional Chinese medicine that widely used as tonic in Asia. The main pharmacologically active components of are the dammarane-type ginsenosides, which have been shown to anti-cancer, anti-inflammatory, immunoregulatory, neuroprotective, and metabolic regulatory activities. Moreover, some ginsenosides (eg, Rh2 Rg3) developed into nutraceuticals. However, utilization clinic restrictive due poor permeability cells low bioavailability human body. Obviously, dammarane skeleton glycosyls responsible for these limitations. Therefore, improving oral has become pressing issue. Here, based on structures we summarized understanding factors affecting introduced methods enhance proposed future perspectives ginsenosides.

Язык: Английский

Процитировано

23

Molecular mechanisms of Codonopsis pilosula in inhibiting hepatocellular carcinoma growth and metastasis DOI
Ning Li,

Ce Yang,

Jing Xia

и другие.

Phytomedicine, Год журнала: 2024, Номер 128, С. 155338 - 155338

Опубликована: Янв. 7, 2024

Язык: Английский

Процитировано

9

Ginsenosides for the treatment of insulin resistance and diabetes: Therapeutic perspectives and mechanistic insights DOI Creative Commons
Tae Hyun Kim

Journal of Ginseng Research, Год журнала: 2024, Номер 48(3), С. 276 - 285

Опубликована: Март 22, 2024

Diabetes mellitus (DM) is a systemic disorder of energy metabolism characterized by sustained elevation blood glucose in conjunction with impaired insulin action multiple peripheral tissues (i.e., resistance). Although extensive research has been conducted to identify therapeutic targets for the treatment DM, its global prevalence and associated mortailty rates are still increasing, possibly because challenges related long-term adherence, limited efficacy, undesirable side effects currently available medications, implying an urgent need develop effective safe pharmacotherapies DM. Phytochemicals have recently drawn attention as novel DM based on their clinical relevance, safety. Ginsenosides, pharmacologically active ingredients primarily found ginseng, long used adjuvants traditional medications Asian countries reported exert promising efficacy various metabolic diseases, including hyperglycemia diabetes. This review summarizes current pharmacological ginsenosides mechanistic insights resistance providing comprehensive perspectives development strategies treat complications.

Язык: Английский

Процитировано

9

Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: a comprehensive review DOI Creative Commons

Yuhan Ma,

Yongxia Zhao,

Mingxia Luo

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Май 7, 2024

Recent research on traditional Chinese medicine (TCM) saponin pharmacokinetics has revealed transformative breakthroughs and challenges. The multicomponent nature of TCM makes it difficult to select representative indicators for pharmacokinetic studies. clinical application saponins is limited by their low bioavailability short half-life, resulting in fluctuating plasma concentrations. Future directions should focus novel compounds utilizing colon-specific delivery osmotic pump systems enhance oral bioavailability. Optimizing drug combinations, such as ginsenosides with aspirin, shows therapeutic potential. Rigorous validation essential practical applications. This review emphasizes a era research, highlighting the need validation. pharmacokinetics, guided principles, are development, multidisciplinary approaches comprehensive understanding. provides theoretical basis new drugs supports rational medication.

Язык: Английский

Процитировано

8

Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd DOI Creative Commons
Xiaoping Song, Lina Wang, Daidi Fan

и другие.

Biomolecules, Год журнала: 2022, Номер 12(4), С. 512 - 512

Опубликована: Март 28, 2022

It is well known that ginsenosides—major bioactive constituents of Panax ginseng—are attracting more attention due to their beneficial pharmacological activities. Ginsenoside Rd, belonging protopanaxadiol (PPD)-type ginsenosides, exhibits diverse and powerful In recent decades, nearly 300 studies on the activities Rd—as a potential treatment for variety diseases—have been published. However, no specific, comprehensive reviews have documented date. The present review not only summarizes in vitro vivo health benefits including anti-cancer, anti-diabetic, anti-inflammatory, neuroprotective, cardioprotective, ischemic stroke, immunoregulation, other effects, it also delves into inclusion molecular mechanisms, providing an overview future prospects use Rd chronic metabolic diseases neurodegenerative disorders. Although biotransformation, pharmacokinetics, clinical reviewed, trial data are limited; available its acute stroke. Therefore, evidence should be considered studies.

Язык: Английский

Процитировано

30

Progress in the Conversion of Ginsenoside Rb1 into Minor Ginsenosides Using β-Glucosidases DOI Creative Commons

Hongrong Zhu,

Rui Zhang, Zunxi Huang

и другие.

Foods, Год журнала: 2023, Номер 12(2), С. 397 - 397

Опубликована: Янв. 13, 2023

In recent years, minor ginsenosides have received increasing attention due to their outstanding biological activities, yet they are of extremely low content in wild ginseng. Ginsenoside Rb1, which accounts for 20% the total ginsenosides, is commonly used as a precursor produce via β-glucosidases. To date, many research groups different approaches obtain β-glucosidases that can hydrolyze ginsenoside Rb1. This paper provides compilation and analysis relevant literature published mainly last decade, focusing on enzymatic hydrolysis pathways, characteristics molecular mechanisms Rb1 by Based this, it be concluded that: (1) The convert derived from bacteria fungi classified glycoside hydrolase (GH) families 1 3, through six pathways. (2) Almost all these acidic neutral enzymes with masses ranging 44–230 kDa. Furthermore, vary widely terms optimal temperature, degradation products kinetics. (3) contrast GH1 β-glucosidases, GH3 show close sequence-function relationships. Mutations affecting substrate binding site might alter catalytic efficiency yield prosapogenins. Further studies should focus elucidating improving overall performances better application food pharmaceutical industries.

Язык: Английский

Процитировано

19

Dietary phytochemicals: As a potential natural source for treatment of Alzheimer's Disease DOI Creative Commons
Renying Zhuo,

Haixia Yang,

Chenhui Zhu

и другие.

Food Innovation and Advances, Год журнала: 2023, Номер 2(1), С. 36 - 43

Опубликована: Янв. 1, 2023

Alzheimer's disease (AD) is a common neurodegenerative disease, which seriously impairs human health and life. At present, scientists have proposed more than dozen hypotheses about the pathogenesis of AD, including tau propagation hypothesis. However, exact ultimate pathogenic factor AD remains unknown. Based on current hypotheses, some anti-AD drugs (e.g., donepezil Ketamine) been developed used in clinical treatment, fall into two main categories, acetylcholinesterase inhibitors (AChEIs) N-methyl-D-aspartate (NMDA) receptor antagonists, former representative drug donepezil, latter memantine. Since these undesirable side effects, it necessary to find safer alternatives for treatment. Interestingly, dietary phytochemicals advantages wide source, safety, high biological activity, natural route screening drugs. In this study, several representatives' with effect, resveratrol, lycopene, gallic acid, berberine, ginsenoside Rg1, pseudoginsenoside-F11, Rh2, artemisinin, torularhodin were selected from published data over last 10 years their potential molecular mechanisms applications reviewed treatment AD.

Язык: Английский

Процитировано

18

Ginsenoside Rd: A promising target for ischemia-reperfusion injury therapy (A mini review) DOI Open Access

Qiupeng Feng,

Lijing Ling,

Yuan Hua

и другие.

Biomedicine & Pharmacotherapy, Год журнала: 2024, Номер 171, С. 116111 - 116111

Опубликована: Янв. 5, 2024

Ischemia-reperfusion injury (IRI) represents a prevalent pathological phenomenon. Traditional treatment approaches primarily aim at restoring blood supply to ischemic organs, disregarding the consequent damage caused by IRI. Belonging class of protopanaxadiol ginsenosides that are found in Panax ginseng, ginsenoside Rd (GSRd) demonstrates notable safety alongside diverse range biological functions. Its active components exhibit pharmacological effects, encompassing anti-inflammatory, anti-tumor, neuroprotective, cardiovascular-protective, and immune-regulatory properties, making it promising candidate for addressing multiple medical conditions. GSRd shields against I/R employing crucial cellular mechanisms, including attenuation oxidative stress, reduction inflammation, promotion cell survival signaling pathways, inhibition apoptotic pathways. Additionally, regulates mitochondrial function, maintains calcium homeostasis, modulates expression genes involved injury. This review seeks consolidate mechanism action within context Our objective is contribute advancement GSRd-related pharmaceuticals provide novel insights clinicians developing IRI strategies.

Язык: Английский

Процитировано

7